menu
    • menu

    Company profile for Nivagen

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world. Our sales and marketing personnel are among the best in the world. The US generic prescription market is ...
    Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world. Our sales and marketing personnel are among the best in the world. The US generic prescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in next 10 years.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NivagenUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3100 Fite Cir, Suite 208, Sacramento, California 95827
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nivagen.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of October 9, 2024
    Enforcement Report - Week of October 9, 2024

    09 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-9-2024-25441.pdf

    FDA
    09 Oct 2024
    Share Share
    Nivagen Sells MedisourceRx To Hims & Hers
    Nivagen Sells MedisourceRx To Hims & Hers

    23 Sep 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-09-23/nivagen-pharmaceuticals-sells-medisourcerx-business-unit-to-hims-hers/?widget=listSection

    CONTRACT PHARMA
    23 Sep 2024
    Share Share
    Nivagen Pharmaceuticals Sells MedisourceRx Business Unit
    Nivagen Pharmaceuticals Sells MedisourceRx Business Unit

    23 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240923141087/en

    BUSINESSWIRE
    23 Sep 2024
    Share Share
    Persist AI And Nivagen Partner On AI-Driven Injectable Manufacturing
    Persist AI And Nivagen Partner On AI-Driven Injectable Manufacturing

    12 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/persist-ai-and-nivagen-to-collaborate-on-ai-driven-manufacturing-process-for-long-acting-injectable-302217034.html

    PR NEWSWIRE
    12 Aug 2024
    Share Share
    Nivagen's Generic Zinc Sulfate Receives Approval in US
    Nivagen's Generic Zinc Sulfate Receives Approval in US

    05 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214597

    FDA
    05 Jul 2024
    Share Share
    Nivagen's Generic Remifentanil Hydrochloride Receives Approval in US
    Nivagen's Generic Remifentanil Hydrochloride Receives Approval in US

    28 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215635

    FDA
    28 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search